Immunotherapy, an approach that seeks to stimulate the immune system to attack and destroy cancer cells, is a new field of research…
OTLC’s Deciparticle(TM) platform reliably formulates diverse hydrophobic drugs—including macrolide mTOR inhibitors, peptides, and polyketides—into uniform, IV-ready nanoparticles. Current Preclinical PK…
Soligenix reported that SGX302 was well tolerated by all patients in cohort 3, with no drug-related adverse events identified during the treatment period.…
A recent report from India is a stark reminder of ricin’s accessibility and the pressing need for effective countermeasures. Ricin…
The U.S. House of Representatives passed a healthcare bill that didn’t include an extension of the ACA tax credits that…
In the U.S. about 15 million individuals live with long Covid, according to Department of Health & Human Services. For a long time, the scientific community…
Research indicates that the advantages of nanoparticle delivery in pharma are significant Oncotelic Therapeutics has advanced nanoparticle-based delivery strategies through…
A new study done in India has produced results that bring into question the longstanding assumption that treating cancer requires tumors to…
Industry data shows small molecules achieve 5–10% approval rates over 15–20 years; antisense oligonucleotides (“ASOs”) are shifting the odds through…
A study that involved an analysis of patient records in New York has discovered that breast cancer, and especially aggressive…